SE436831B - Forfarande for framstellning av lekemedelsformer for oral administrering - Google Patents
Forfarande for framstellning av lekemedelsformer for oral administreringInfo
- Publication number
- SE436831B SE436831B SE7507413A SE7507413A SE436831B SE 436831 B SE436831 B SE 436831B SE 7507413 A SE7507413 A SE 7507413A SE 7507413 A SE7507413 A SE 7507413A SE 436831 B SE436831 B SE 436831B
- Authority
- SE
- Sweden
- Prior art keywords
- liquid
- cholesterol
- ethoxylated
- emulsifiers
- process according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH920474 | 1974-07-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7507413L SE7507413L (sv) | 1976-01-05 |
| SE436831B true SE436831B (sv) | 1985-01-28 |
Family
ID=4349465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7507413A SE436831B (sv) | 1974-07-04 | 1975-06-27 | Forfarande for framstellning av lekemedelsformer for oral administrering |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5132722A (ja) |
| AT (1) | AT359196B (ja) |
| AU (1) | AU507674B2 (ja) |
| BE (1) | BE831041A (ja) |
| CA (1) | CA1057196A (ja) |
| DE (1) | DE2528257C2 (ja) |
| ES (1) | ES439074A1 (ja) |
| FR (1) | FR2276833A1 (ja) |
| GB (1) | GB1513383A (ja) |
| HK (1) | HK17281A (ja) |
| HU (1) | HU172531B (ja) |
| IE (1) | IE41573B1 (ja) |
| IL (1) | IL47623A (ja) |
| MY (1) | MY8100372A (ja) |
| NL (1) | NL7507745A (ja) |
| PH (1) | PH13763A (ja) |
| SE (1) | SE436831B (ja) |
| ZA (1) | ZA754303B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1090703B (it) * | 1976-12-03 | 1985-06-26 | Scherer Ltd R P | Perfezionamento nelle composizioni utili quali veicolo per farmaci |
| DE2707878C2 (de) * | 1977-02-24 | 1986-01-30 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren |
| FI793888A (fi) * | 1978-12-21 | 1980-06-22 | Sandoz Ag | Galeniska blandningar |
| JPS56104813A (en) * | 1980-01-25 | 1981-08-20 | Takeda Chem Ind Ltd | Composition for rectal infusion containing compound having beta-lactam ring |
| AU543727B2 (en) | 1980-06-02 | 1985-05-02 | Ayerst Mckenna & Harrison Inc. | Injectable composition of rapamycin |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| DE3829643A1 (de) * | 1988-09-01 | 1990-03-15 | Roecar Holdings Nv | Phyto- und zoosterole und deren derivate mit verbesserter wasserloeslichkeit |
-
1975
- 1975-06-25 DE DE2528257A patent/DE2528257C2/de not_active Expired
- 1975-06-27 SE SE7507413A patent/SE436831B/sv not_active IP Right Cessation
- 1975-06-30 NL NL7507745A patent/NL7507745A/xx not_active Application Discontinuation
- 1975-06-30 GB GB27470/75A patent/GB1513383A/en not_active Expired
- 1975-07-02 IE IE1468/75A patent/IE41573B1/en unknown
- 1975-07-02 PH PH17338A patent/PH13763A/en unknown
- 1975-07-02 IL IL47623A patent/IL47623A/xx unknown
- 1975-07-02 HU HU75SA00002815A patent/HU172531B/hu not_active IP Right Cessation
- 1975-07-02 ES ES439074A patent/ES439074A1/es not_active Expired
- 1975-07-03 AU AU82736/75A patent/AU507674B2/en not_active Expired
- 1975-07-03 CA CA230,702A patent/CA1057196A/en not_active Expired
- 1975-07-03 FR FR7520947A patent/FR2276833A1/fr active Granted
- 1975-07-03 AT AT510975A patent/AT359196B/de not_active IP Right Cessation
- 1975-07-03 JP JP50081486A patent/JPS5132722A/ja active Pending
- 1975-07-04 ZA ZA754303A patent/ZA754303B/xx unknown
- 1975-07-04 BE BE158021A patent/BE831041A/xx not_active IP Right Cessation
-
1981
- 1981-04-30 HK HK172/81A patent/HK17281A/xx unknown
- 1981-12-30 MY MY372/81A patent/MY8100372A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE41573B1 (en) | 1980-01-30 |
| FR2276833A1 (fr) | 1976-01-30 |
| GB1513383A (en) | 1978-06-07 |
| ATA510975A (de) | 1980-03-15 |
| ES439074A1 (es) | 1977-05-16 |
| CA1057196A (en) | 1979-06-26 |
| IL47623A0 (en) | 1975-10-15 |
| IL47623A (en) | 1979-05-31 |
| DE2528257C2 (de) | 1986-02-13 |
| AT359196B (de) | 1980-10-27 |
| HU172531B (hu) | 1978-09-28 |
| HK17281A (en) | 1981-05-08 |
| SE7507413L (sv) | 1976-01-05 |
| JPS5132722A (ja) | 1976-03-19 |
| BE831041A (fr) | 1976-01-05 |
| AU507674B2 (en) | 1980-02-21 |
| FR2276833B1 (ja) | 1978-11-10 |
| MY8100372A (en) | 1981-12-31 |
| ZA754303B (en) | 1977-02-23 |
| AU8273675A (en) | 1977-01-06 |
| IE41573L (en) | 1976-01-04 |
| DE2528257A1 (de) | 1976-01-22 |
| PH13763A (en) | 1980-09-18 |
| NL7507745A (nl) | 1976-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69837903T2 (de) | Feste pharmazeutische Dispersionen mit erhöhter Bioverfügbarkeit | |
| EP1487416B1 (en) | Drug microparticles | |
| TWI428125B (zh) | 對包括vx-950之藥物實施噴霧乾燥之方法及由此方法製備之產物 | |
| DE69823663T2 (de) | Selbstemulgierbare formulierung enthaltend lipophile verbindungen | |
| ES2240222T3 (es) | Procedimiento para producir particulas nanometricas mediante secado por pulverizacion en lecho fluidizado. | |
| DE69624564T2 (de) | Misoprostolhaltige feste stabilisierte dispersionen | |
| EP0326618A1 (en) | Medicinal composition containing albumin as carrier and process for its preparation | |
| WO1995022982A1 (en) | Cyclosporin-containing powder composition | |
| JP2001505928A (ja) | シクロスポリン及び陰イオン性界面活性剤を含む固体医薬組成物 | |
| EP1741424B1 (en) | Solid pharmaceutical dispersions with enhanced bioavailabilty | |
| JP2007501218A (ja) | 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物 | |
| DE69129918T2 (de) | Ein in Wasser schwerlösliches Arzneimittel enthaltende pharmazeutische Zubereitung | |
| KR100367302B1 (ko) | 소수성활성물질과발포제를포함하는제약학적조성물과이의준비공정 | |
| KR100209201B1 (ko) | 1,4-디히드로피리딘 유도체를 함유하는 고체 분산 정제 및 그의 제조방법 | |
| SE436831B (sv) | Forfarande for framstellning av lekemedelsformer for oral administrering | |
| ES2286655T3 (es) | Reduccion del tamaño de particulas de compuestos bioactivos. | |
| JPH07121858B2 (ja) | 熱で脱水したエマルジョン組成物 | |
| EP3854384A1 (en) | Pharmaceutical formulation comprising abiraterone acetate | |
| DK169566B1 (da) | Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet | |
| JPH021403A (ja) | 医薬組成物 | |
| JPS63119426A (ja) | 肝疾患治療薬組成物 | |
| JPS6218527B2 (ja) | ||
| KR20030074822A (ko) | 약학 조성물 | |
| JPS6348228A (ja) | 難溶性薬物の易吸収性固形製剤 | |
| KR19990075252A (ko) | 비가역성 hiv프로테아제 억제제를 포함하는 경구투여용 약학적 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7507413-8 Effective date: 19920109 Format of ref document f/p: F |